New York · 2025 Regular Session · Bill
S 10232: Relates to not requiring prior authorization for certain cancer treatments
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 10232 is a bill introduced in the New York Senate on May 7, 2026. According to its official title, it concerns: Relates to not requiring prior authorization for certain cancer treatments. Primary sponsor: Pete Harckham (Democratic/Working Families). Most recent recorded action (May 7, 2026): REFERRED TO INSURANCE.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Relates to not requiring a prior authorization determination for certain categories of cancer treatments based on National Comprehensive Cancer Network Guidelines.
Sponsors
Sponsors by party (alphabetical): Democratic/Working Families 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Pete Harckham | Primary sponsor | Democratic/Working Families | Senate | 40 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO INSURANCE